Skip to content
Catalyst
Search

Papers/PMID:22045518

Hypovitaminosis D and response to cholecalciferol supplementation in patients with autoimmune and non-autoimmune rheumatic diseases.

Rheumatology international2012The record

1 finding · 1 compound · 1 endpoint

What it reported

How to read these marks

What moved

1 finding

  • calciol — increases serum 25-hydroxyvitamin D concentration

    Evidence strength: very limited.Findingreplicated ×33
    “Cholecalciferol supplementation increased 25(OH)vitamin D plasma concentration equally in both ARD and NARD; however, only 29/100 patients reached a plasma level ≥75 nmol/l without differences between ARD and NARD (χ(2) = n.s.).”
    Quoted verbatim from Hypovitaminosis D and response to cholecalciferol supplementation in patients with autoimmune and non-autoimmune rheumatic diseases..
    Study
    cohort
    Dose
    750-1,000 UI/die, stated in the abstract as 25(OH)vitamin D supplementation; later called cholecalciferol
    Population
    100 adult patients with autoimmune (43) or non-autoimmune (57) rheumatic diseases supplemented for at least 6 months; retrospective, before-and-after comparison with baseline

    Hypovitaminosis D and response to cholecalciferol supplementation in patients with autoimmune and non-autoimmune rheumatic diseases.2012PMID:2204551810.1007/s00296-011-2170-xPermalink